Tower Research Capital (TRC)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,928
| Closed | -$336K | – | 6573 |
|
|
2023
Q1 | $336K | Buy |
13,928
+13,553
| +3,614% | +$327K | 0.01% | 1076 |
|
|
2022
Q4 | $4K | Sell |
375
-26,164
| -99% | -$279K | ﹤0.01% | 5132 |
|
|
2022
Q3 | $119K | Buy |
26,539
+18,180
| +217% | +$81.5K | ﹤0.01% | 2426 |
|
|
2022
Q2 | $33K | Buy |
8,359
+2,035
| +32% | +$8.03K | ﹤0.01% | 3289 |
|
|
2022
Q1 | $46K | Buy |
6,324
+1,379
| +28% | +$10K | ﹤0.01% | 2812 |
|
|
2021
Q4 | $28K | Buy |
4,945
+592
| +14% | +$3.35K | ﹤0.01% | 3322 |
|
|
2021
Q3 | $28K | Buy |
4,353
+518
| +14% | +$3.33K | ﹤0.01% | 3441 |
|
|
2021
Q2 | $32K | Sell |
3,835
-12,928
| -77% | -$108K | ﹤0.01% | 3437 |
|
|
2021
Q1 | $176K | Buy |
16,763
+13,457
| +407% | +$141K | ﹤0.01% | 2126 |
|
|
2020
Q4 | $56K | Sell |
3,306
-36,945
| -92% | -$626K | ﹤0.01% | 3007 |
|
|
2020
Q3 | $516K | Buy |
40,251
+38,147
| +1,813% | +$489K | 0.01% | 1649 |
|
|
2020
Q2 | $30K | Buy |
+2,104
| New | +$30K | ﹤0.01% | 3447 |
|
|
2020
Q1 | – | Sell |
-7,301
| Closed | -$109K | – | 4178 |
|
|
2019
Q4 | $109K | Sell |
7,301
-12,844
| -64% | -$192K | 0.01% | 889 |
|
|
2019
Q3 | $137K | Buy |
+20,145
| New | +$137K | 0.01% | 1182 |
|
|
2019
Q2 | – | Sell |
-960
| Closed | -$2K | – | 4504 |
|
|
2019
Q1 | $2K | Sell |
960
-2,257
| -70% | -$4.7K | ﹤0.01% | 3488 |
|
|
2018
Q4 | $6K | Sell |
3,217
-1,955
| -38% | -$3.65K | ﹤0.01% | 2838 |
|
|
2018
Q3 | $21K | Buy |
+5,172
| New | +$21K | ﹤0.01% | 2320 |
|